Shanghai Rightongene Biotechnology Co., Ltd. Stock
Equities
688217
CNE100005212
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.9 CNY | +0.42% | -0.17% | -33.20% |
Sales 2024 * | 311M 42.95M | Sales 2025 * | 375M 51.79M | Capitalization | 1.33B 184M |
---|---|---|---|---|---|
Net income 2024 * | 11M 1.52M | Net income 2025 * | 14M 1.93M | EV / Sales 2024 * | 4.29 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.56 x |
P/E ratio 2024 * |
114
x | P/E ratio 2025 * |
95.6
x | Employees | 501 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.68% |
1 day | +0.42% | ||
1 week | -0.17% | ||
1 month | -7.54% | ||
3 months | -8.39% | ||
6 months | -39.57% | ||
Current year | -33.20% |
Managers | Title | Age | Since |
---|---|---|---|
Hui Xiong
CEO | Chief Executive Officer | 52 | 12-02-16 |
Yan Li
DFI | Director of Finance/CFO | 42 | 20-03-26 |
Jun Xiong
BRD | Director/Board Member | 48 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Wei Yuan
BRD | Director/Board Member | 52 | 18-12-12 |
Gui Ying Zhao
BRD | Director/Board Member | 70 | 18-12-12 |
Guang Ce Jiang
BRD | Director/Board Member | 53 | 23-08-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 23.9 | +0.42% | 190,938 |
24-05-30 | 23.8 | +1.23% | 249,728 |
24-05-29 | 23.51 | +1.03% | 420,362 |
24-05-28 | 23.27 | -3.96% | 391,822 |
24-05-27 | 24.23 | +1.21% | 522,522 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.20% | 184M | |
-3.17% | 8.22B | |
+6.11% | 5.72B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- 688217 Stock